$39.57
2.59% day before yesterday
NYSE, Feb 21, 10:10 pm CET
ISIN
NL0012169213
Symbol
QGEN

QIAGEN NV Stock price

$39.57
-9.29 19.01% 1M
-8.83 18.25% 6M
-6.23 13.61% YTD
-4.52 10.26% 1Y
-12.05 23.34% 3Y
-0.07 0.17% 5Y
+12.42 45.72% 10Y
NYSE, Closing price Fri, Feb 21 2025
+1.00 2.59%
ISIN
NL0012169213
Symbol
QGEN
Sector

Key metrics

Market capitalization $8.61b
Enterprise Value $8.85b
P/E (TTM) P/E ratio 106.51
EV/FCF (TTM) EV/FCF 17.48
EV/Sales (TTM) EV/Sales 4.47
P/S ratio (TTM) P/S ratio 4.35
P/B ratio (TTM) P/B ratio 2.40
Dividend yield 3.43%
Last dividend (FY24) $1.36
Revenue growth (TTM) Revenue growth 0.66%
Revenue (TTM) Revenue $1.98b
EBIT (operating result TTM) EBIT $491.64m
Free Cash Flow (TTM) Free Cash Flow $506.38m
Cash position $1.15b
EPS (TTM) EPS $0.37
P/E forward 19.86
P/S forward 4.23
EV/Sales forward 4.35
Short interest 1.54%
Show more

Is QIAGEN NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,815 stocks worldwide.

QIAGEN NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a QIAGEN NV forecast:

13x Buy
57%
10x Hold
43%

Analyst Opinions

23 Analysts have issued a QIAGEN NV forecast:

Buy
57%
Hold
43%

Financial data from QIAGEN NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,978 1,978
1% 1%
100%
- Direct Costs 713 713
4% 4%
36%
1,423 1,423
16% 16%
72%
- Selling and Administrative Expenses 580 580
55% 55%
29%
- Research and Development Expense 193 193
3% 3%
10%
695 695
7% 7%
35%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 492 492
10% 10%
25%
Net Profit 84 84
76% 76%
4%

In millions USD.

Don't miss a Thing! We will send you all news about QIAGEN NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

QIAGEN NV Stock News

Neutral
GlobeNewsWire
5 days ago
The FFPE tissue samples for genomics study & analysis market is poised for significant growth, driven by rising cancer incidence, advancements in genomic technologies, and an increasing focus on personalized medicine. These samples play a crucial role in cancer research, enabling detailed genetic profiling and better therapeutic strategies. Despite challenges like regulatory constraints and hig...
Neutral
Business Wire
10 days ago
VENLO, The Netherlands & REDWOOD CITY, Calif.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the official opening of a new data center in Melbourne, Australia, designed to strengthen its global bioinformatics leadership position in this region of the world. This latest addition reflects QIAGEN's ongoing commitment to enhance its bioinformatics data infrastr...
Neutral
Seeking Alpha
17 days ago
Qiagen N.V. (NYSE:QGEN ) Q4 2024 Earnings Conference Call February 6, 2025 10:00 AM ET Company Participants John Gilardi – Vice President, Head of Corporate Communications and Investor Relations Thierry Bernard – Chief Executive Officer Roland Sackers – Chief Financial Officer Conference Call Participants Tycho Peterson – Jefferies Michael Ryskin – Bank of America Securities Patrick Donnelly – ...
More QIAGEN NV News

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Thierry Bernard
Founded 1996
Website www.qiagen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today